Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

CT scans can find serious prostate cancer even when PSA levels are low.

Cedrol may be an effective treatment for colorectal cancer.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Early baldness in men may indicate a higher risk of prostate cancer.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

A pathway helps maintain long telomeres in both stem and cancer cells.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Prostate cancer risk is not linked to blood testosterone levels.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.